Ishita Kamboj

Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study

Transplantation and Cellular Therapy · 2026 · 5 citations

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

Clinical Lymphoma · 2026 · First of 18 authors · Corresponding · 2 citations